Editorial commentary: should 13-valent protein-conjugate pneumococcal vaccine be used routinely in adults?

Editorial

Daniel M Musher. Clin Infect Dis. 2012 Jul.

. 2012 Jul;55(2):265-7.

doi: 10.1093/cid/cis364. Epub 2012 Apr 11.

No abstract available

Comment in

Pneumococcal polysaccharide vaccine efficacy and routine use of conjugate vaccines in infants: there is no need for a vaccine program in older adults at present.
Trück J, Lazarus R, Jonsdottir I, Klugman KP, Pollard AJ. Trück J, et al. Clin Infect Dis. 2012 Dec;55(11):1577-9; author reply 1579-81. doi: 10.1093/cid/cis700. Epub 2012 Aug 17. Clin Infect Dis. 2012. PMID: 22903769 No abstract available.

Effectiveness and serotype coverage: key criteria for pneumococcal vaccines for adults.
Grabenstein JD. Grabenstein JD. Clin Infect Dis. 2012 Jul;55(2):255-8. doi: 10.1093/cid/cis354. Epub 2012 Apr 11. Clin Infect Dis. 2012. PMID: 22495543 No abstract available.
Pneumococcal conjugate vaccine for adults: a new paradigm.
Paradiso PR. Paradiso PR. Clin Infect Dis. 2012 Jul;55(2):259-64. doi: 10.1093/cid/cis359. Epub 2012 Apr 11. Clin Infect Dis. 2012. PMID: 22495545 Free PMC article.